New anti-HSV therapeutics target the helicase-primase complex (Q43943677)

28 November 2017

title

New anti-HSV therapeutics target the helicase-primase complex (English)

1 reference

28 November 2017

Clyde S Crumpacker

1

1 reference

28 November 2017

Priscilla A Schaffer

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

8

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

327-328

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0402-327

28 November 2017

exact match

0 references

cites work

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

Herpes simplex virus DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0402-327

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0402-327

1 reference

28 November 2017

1 reference